CoolCurve+ Applicator Launch

Slides:



Advertisements
Similar presentations
This document and the contents hereof are considered proprietary and confidential information of ZELTIQ Aesthetics, Inc. Disclosure to unauthorized individuals.
Advertisements

Confidentiality, Consent and Data Protection Elizabeth M Robertson Deputy Medical Director Grampian University Hospitals Trust.
Steve Fuller InforMedix Marketing Research, Inc. Medical-Surgical Market Research Group April 3, 2008.
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
Conductive Keratoplasty for the Treatment of Presbyopic Emmetropes and Hyperopes to Improve Near Vision FDA Clinical Trial Protocol RCS-0110PRS 24 Month.
Focused on Pulmonology and Hepatology
Program Development for the Treatment of Torticollis and Plagiocephaly LAURA FLYNN, PT, PCS AMY L. ROSEN, MPT, CLT.
15 The Health Record.
Approach to Obesity DR.YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM Consultant Family Medicine Associatet professor King Khalid University Hospital College.
09/07/11 Contract No inCASA Integrated Network for Completely Assisted Senior citizen’s Autonomy Evaluation ICT Policy Support Programme Call 3.
PATIENT SATISFACTION AND WHY IT MATTERS. Why It Matters  CMS (Centers for Medicare & Medicaid Services), hospitals and insurance providers are using.
Nutrition Education for Cancer Care N.E.C.C. Nutrition Education for Cancer Care (NECC) Total Funding Requested: $100, Project Duration: 8 Months.
Virtual Core Strengthening A primer for identifying and strengthening the core muscles.
Safety, Efficacy and Duration of Effect of RT002, a Botulinum Toxin Type A for Injection, to Treat Glabellar Lines: The Phase 2 BELMONT Study Authors:
Division of Plastic Surgery University of Puerto Rico Norma I. Cruz, MD Nothing to disclose.
Responsibilities of Sponsor, Investigator and Monitor
In the U.S., the CoolSculpting procedure is FDA-cleared for the treatment of visible fat bulges in the submental area, thigh, abdomen and flank. In Taiwan,
Eliminate Stubborn Fat
Research Participant Satisfaction
NCAHRMM Spring conference
Workforce Development Domain Task Force
Documentation in Medical Settings
Epocrates Online physician user survey
Mosaic Workshop - Ottawa
BROOKHAVEN HOSPITAL’S
Responsibilities of Sponsor, Investigator and Monitor
Design & Product Development Larry L Wood
Clinical outcomes among patients with chronic low back pain treated with pregabaline monotherapy in fort portal regional referral hospital, “case series”
Seema Jain1, Rebecca Andridge2, Jessica Hellings3
CoolSculpting® Procedure Results
Study Feasibility and Start-up
Fitness testing and training
BIPAI Network Experience with multi-month prescribing/refills (MMP)
Ololade Olakanmi American Medical Association November 2007
Module 17: MIXING ZONES A limited area or volume of water where initial dilution of a discharge takes place and where numeric water quality criteria.
Dr. Daz (Karoline) Harding GP in Public Health NHS Wiltshire
Alcohol, Other Drugs, and Health: Current Evidence
Webinar November 21, :30-3:30 Eastern Standard Time
Updates on Policy #38 Addressing Subjects with Non-Average Heights and Weights 2017 SWOG Fall Meeting BOG Siu Fun Wong, PharmD Co-Chair, Pharmaceutical.
Ageing firefighters may impair the quality of emergency responses.
The early use of Antibiotics in at Risk CHildren with InfluEnza
POLYPHARMACY IN GERIATRIC PATIENTS Dr SHREYAS MISTRY MD, Dr MAYUR RALI MD HOFSTRA-North Shore LIJ School of Medicine Department of Family Medicine Southside.
Martha Carvour, MD, PhD March 2, 2017
From: Minimal-Scar Handlift: A New Surgical Approach
Abutment connect radiograph 12 month follow-up radiograph
Add practice name & logo
Acne Scars B&A Pictures
TECHjOSH.COM TechJosh.com.
Crucial Statistical Caveats for Percutaneous Valve Trials
Getting a Study Done at Jefferson:
Research Participant Satisfaction
School of Engineering & Sciences
Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
Darwen Healthlink Patient survey – 2017/2018 Results & analysis
Bolder communication helps diagnose malnutrition
Tangrams 1. Question & Research Task
8_84 Apollo Sugar Clinic: Diabetes surveillance campaign Screening Population Based on Body mass Index Apollo Sugar holds the Proprietary right for the.
Wellbeing Symposium 2018 Mytime Active Showcasing
Bolder communication helps diagnose malnutrition
Hallett H. Mathews, M.D. Richmond, Virginia
Pharmacy practice and the healthcare system Ola Ali Nassr
SMART Fitness Plan! 1. Question & Research Task
8_84 Apollo Sugar Clinic: Diabetes surveillance campaign Screening Population Based on Age Apollo Sugar holds the Proprietary right for the content presented.
Curriculum Coordinator: Pamela Quinn Date of Presentation: 1/19/18
Whole-Person Care for the Seriously Mentally Ill Patient in a
8_84 Apollo Sugar Clinic: Diabetes surveillance campaign Screening Population Based on Gender Apollo Sugar holds the Proprietary right for the content.
Module 16 Safe Patient Handling.
Presenter Disclosure Information
8_84 Apollo Sugar Clinic: Diabetes surveillance campaign Screening Population Based on RBS Apollo Sugar holds the Proprietary right for the content presented.
Presentation transcript:

CoolCurve+ Applicator Launch

Introducing the CoolCurve+ Applicator The new CoolCurve+ (“CoolCurve Plus”) applicator is anatomically designed to optimize fit on patients’ bodies. The curved cooling plate allows for better fit and tissue draw, which may yield improved outcomes. Curved cooling plate enables better fit and tissue draw Slim side profile for better usability As the newest addition to our CoolSculpting product line, the CoolCurve+ provides you with increased versatility to treat a multitude of body shapes to attract more patients and grow your practice. IC 1218

CoolCurve+ Optimizes Fit & Tissue Draw On some patients, the CoolCurve (eZ App 6.2) applicator does not provide a tight fit and seal, thus compromising placement and tissue draw. The CoolCurve+ applicator has a curved cooling plate to enable better placement and fit onto the patient’s body. Better tissue draw results. IC 1218

CoolCurve+ Development Research Research conducted in Japan and U.S. 55 typical patients assessed # of Females/ Males 34/ 21 Average Age: 39.9 Average Female BMI: 23.5 Average Male BMI: 25.7 6 different applicator prototypes tested 49 of 55 (89%) demonstrated best fit with one template Template 44 on an Asian patient IC 1218 This document and the contents hereof are considered proprietary and confidential information of ZELTIQ Aesthetics, Inc. Disclosure to unauthorized individuals or dissemination, publication or copying is prohibited without prior written consent of ZELTIQ.

CoolCurve+ Development Research Patient who is too narrow for CoolCurve (eZ App 6.2) Applicator is able to achieve 4cm of tissue draw with the prototype CoolCurve+ applicator. IC 1218

Performance Study Study conducted by Dr. Eric Bachelor in Pleasanton, CA (April 2012) CoolCurve+ performance was assessed on flank area 25 subjects (BMI ≤ 29) Results assessed at 2 and 4 months Key Findings: No serious adverse events High patient satisfaction IC 1218

High Patient Satisfaction 100% Would Recommend CoolSculpting to a Friend 80% said CoolSculpting met or exceeded expectations IC 1218

Physician Assessment of Fit & Draw CoolCurve+ was compared to CoolCurve applicator to evaluate fit and tissue draw Total of 29 subjects (BMI <25) Assessment performed on the flank Conducted at 3 clinical sites Dr. Henry Chan (Hong Kong) Dr. Joyce Lim (Singapore) Dr. Chih-Hsun Yang (Taiwan) CoolCurve+ on flank 83% had better fit 76% had better draw 14% more patients could be treated who did not have adequate tissue draw with CoolCurve CoolCurve (eZ App 6.2) on flank IC 1218

CoolCurve+ Patient Results Before Treatment on both flanks Procedure by Dr. Henry Chan 3 Months After One CoolSculpting® Treatment IC 1218

CoolCurve+ Patient Results Before Treatment on left flank only Procedure by Dr. Eric Bachelor 4 Months After One CoolSculpting® Treatment +1.4 kg weight change at follow-up visit. IC 1218

CoolCurve+ Patient Results Before Treatment on right flank only Procedure by Dr. Eric Bachelor 4 Months After One CoolSculpting® Treatment No weight change at follow-up visit. IC 1218

CoolCurve+ hands-on exercise Kevin Springer, Clinical Engineering Manager IC 1218

CoolCurve+ White Paper

Thank you! IC 1218